Asthma Flashcards
what is asthma
chronic inflammatory disorder of the airways, secondary to type 1 hypersensitivity, that causes episodic bronchospasm resulting in airway obstruction
risk factors for developing asthma
atopy
family history of atopy / asthma
maternal smoking during pregnancy / smoking around child
symptoms of asthma
SOB
dry cough - worse at night
wheeze
signs of asthma on examination
expiratory wheeze on auscultation
reduced Peak flow
what things can trigger symptoms of asthma
exercise stress animal dander dust infections cold air
what is spirometry
measures the amount (volume) and speed (flow) of air during inhalation and exhalation
differentiates disorders as
- obstructive: e.g. asthma where there is obstruction of airflow due to bronchoconstriction
- restrictive: e.g. fibrosis where there is restriction of the lung
what is
- FEV1
- FVC
FEV1 = forced expiratory volume (amount of air person can exhale as fast as they can in 1 second)
- reduced if any obstruction to air flow out of lungs
FVC = forced vital capacity (total amount of air person can exhale after max inhalation)
- reduced if any restriction on the capacity of the lungs
spirometry results in asthma
FEV1 - significantly reduced
FVC - normal
FEV1/FVC ratio < 70% = obstructive disease
what does the airway obstruction in asthma respond to
bronchodilators - termed ‘bronchodilator reversibility’
- will improve obstructive picture
apart from spirometry, what other tests are useful in asthma diagnosis
fractional inhaled nitrous oxide
- levels rise in correlation with eosinophilic inflammation in asthma
peak flow
1st line drug given in asthma
short acting beta 2 agonist (SABA) e.g. salbutamol
- a ‘reliever’ drug when patient experiences symptoms
common side effect of salbutamol
tremor
2nd line drug if SABA insufficient alone
SABA + Inhaled corticosteroid (ICS) e.g beclametasone
- taken everyday regardless of if patient has symptoms
- termed ‘preventer’
common side effect of ICS
oral candidiasis
stunted growth in children
3rd line drug if SABA + ICS insufficient
add oral leukotriene receptor antagonist e.g. montelukast